PDMRs exercise of EIP options
Updated : 15:25
AJ Bell plc
("AJ Bell", the "Company")
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
The Company announces that it has been notified that the PDMRs who are named in column (1) of the below table exercised nominal cost options under the Company's Executive Incentive Plan (EIP) on 13 March 2020 to acquire the number of Ordinary Shares set alongside their respective names in column (2) of the below table.
(1) | (2) |
PDMR | Number of Ordinary Shares acquired |
Andy Bell | 143,202 |
Michael Summersgill | 54,450 |
Following completion of the exercise of the above EIP options, the PDMRs who are named in column (1) of the below table is interested in the number of Ordinary Shares in the Company and percentage of the Company's issued share capital set alongside their respective names in columns (2) and (3) of the below table.
(1) | (2) | (3) |
PDMR | Number of shares in which interested | % of issued share capital |
Andy Bell | 98,481,297 | 24.01 |
Michael Summersgill | 1,905,250 | 0.46 |
The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further details.
ENQUIRIES
AJ Bell
· Bruce Robinson, Company Secretary +44 (0) 780 234 4859
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Andrew Bell | ||||
2 | Reason for the notification | |||||
a) | Position/status | Chief Executive Officer/PDMR | ||||
b) | Initial notification /Amendment | Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | AJ Bell plc | ||||
b) | LEI | 213800VNKA7DPWXWJJ36 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument | Ordinary Shares | ||||
Identification code | GB00BFZNLB60 | |||||
b) | Nature of the transaction | Exercise of EIP options | ||||
c) | Price(s) and volume(s)
|
| ||||
d) | Aggregated information | Not applicable, single transaction | ||||
Aggregated volume | ||||||
Price | ||||||
e)
| Date of the transaction
| 13 March 2020 | ||||
f) | Place of the transaction | Outside a trading venue |
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Michael Summersgill | ||||
2 | Reason for the notification | |||||
a) | Position/status | Chief Financial Officer/PDMR | ||||
b) | Initial notification /Amendment | Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | AJ Bell plc | ||||
b) | LEI | 213800VNKA7DPWXWJJ36 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument | Ordinary Shares | ||||
Identification code | GB00BFZNLB60 | |||||
b) | Nature of the transaction | Exercise of EIP options | ||||
c) | Price(s) and volume(s)
|
| ||||
d) | Aggregated information | Not applicable, single transaction | ||||
Aggregated volume | ||||||
Price | ||||||
e)
| Date of the transaction
| 13 March 2020 | ||||
f) | Place of the transaction | Outside a trading venue |
Name of officer of issuer responsible for making notification: Bruce Robinson (Company Secretary)
Date of notification: 16 March 2020
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.